Trial Profile
Pilot, phase II, "n-of-1", multiple, crossover, double blind, randomised, placebo-controlled trial of simvastatin against levodopa-induced dyskinesia in Parkinson's disease patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Sep 2013
Price :
$35
*
At a glance
- Drugs Simvastatin (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Acronyms SIMVADYS
- 10 Jun 2011 New trial record